Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 253129.84 Crore) operating in Pharmaceuticals sector.
Sun Pharmaceutical Industries key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-03-2023, the company has reported a Consolidated Total Income of Rs 11303.95 Crore, down -.97 % from last quarter Total Income of Rs 11414.85 Crore and up 18.24 % from last year same quarter Total Income of Rs 9560.35 Crore. Company has reported net profit after tax of Rs 2016.78 Crore in latest quarter.
Investment Rationale
Formed a fresh buying pivot around the record high. Expect the up move to continue.
Promoters held 54.48 per cent stake in the company as of 31-Mar-2023, while FIIs owned 16.88 per cent, DIIs 19.07 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price